TransMedics Group, Inc. (TMDX)Healthcare | Medical Devices | Andover, United States | NasdaqGM
115.87 USD
+6.75
(6.186%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 115.92 +0.05 (0.043%) ⇧ (April 17, 2026, 7:57 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 2:56 p.m. EDT
TMDX is currently in a volatile phase with recent price dips and gains, showing a mix of short-term momentum and long-term fundamentals. While the stock has shown resilience and analyst recommendations are positive, the lack of dividend history and mixed options signals suggest caution. It might be a good opportunity for short-term traders looking for a bounce, but long-term investors should consider the risks and fundamentals carefully. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.122779 |
| AutoARIMA | 0.129584 |
| AutoETS | 0.129584 |
| AutoTheta | 0.132969 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 56.49 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.178 |
| Excess Kurtosis | -1.08 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 109.761 |
| Revenue per Share | 17.812 |
| Market Cap | 4,002,631,936 |
| Trailing P/E | 23.79 |
| Forward P/E | 31.46 |
| Beta | 2.08 |
| Profit Margins | 31.43% |
| Website | https://www.transmedics.com |
As of April 11, 2026, 2:56 p.m. EDT: The options activity indicates mixed signals. The calls show a concentration around the ATM strike (115.0), with significant OI and IV spikes at certain strikes, suggesting potential for price movement. However, the puts show higher OI and IV at lower strikes, indicating some bearish sentiment. Overall, the options market is showing a balance between bullish and bearish expectations, with a slight edge towards caution.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.32090747 |
| Address1 | 200 Minuteman Road |
| Address2 | Suite 302 |
| All Time High | 177.37 |
| All Time Low | 10.0 |
| Ask | 116.35 |
| Ask Size | 1 |
| Audit Risk | 9 |
| Average Analyst Rating | 1.5 - Buy |
| Average Daily Volume10 Day | 813,810 |
| Average Daily Volume3 Month | 894,959 |
| Average Volume | 894,959 |
| Average Volume10Days | 813,810 |
| Beta | 2.082 |
| Bid | 115.51 |
| Bid Size | 1 |
| Board Risk | 3 |
| Book Value | 13.806 |
| City | Andover |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 115.87 |
| Current Ratio | 7.142 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 120.91 |
| Day Low | 113.34 |
| Debt To Equity | 109.761 |
| Display Name | TransMedics |
| Earnings Call Timestamp End | 1,771,968,600 |
| Earnings Call Timestamp Start | 1,771,968,600 |
| Earnings Growth | 11.881 |
| Earnings Quarterly Growth | 14.369 |
| Earnings Timestamp | 1,771,966,800 |
| Earnings Timestamp End | 1,778,184,000 |
| Earnings Timestamp Start | 1,778,184,000 |
| Ebitda | 134,468,000 |
| Ebitda Margins | 0.22208 |
| Enterprise To Ebitda | 29.788 |
| Enterprise To Revenue | 6.615 |
| Enterprise Value | 4,005,537,024 |
| Eps Current Year | 2.45778 |
| Eps Forward | 3.68333 |
| Eps Trailing Twelve Months | 4.87 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 122.6299 |
| Fifty Day Average Change | -6.7598953 |
| Fifty Day Average Change Percent | -0.055124365 |
| Fifty Two Week Change Percent | 32.090748 |
| Fifty Two Week High | 156.0 |
| Fifty Two Week High Change | -40.129997 |
| Fifty Two Week High Change Percent | -0.25724357 |
| Fifty Two Week Low | 86.136 |
| Fifty Two Week Low Change | 29.734001 |
| Fifty Two Week Low Change Percent | 0.3451983 |
| Fifty Two Week Range | 86.136 - 156.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,556,803,800,000 |
| Float Shares | 33,192,081 |
| Forward Eps | 3.68333 |
| Forward P E | 31.457947 |
| Free Cashflow | 94,003,624 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 898 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.59919 |
| Gross Profits | 362,806,016 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03296 |
| Held Percent Institutions | 1.1058999 |
| Implied Shares Outstanding | 34,544,158 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. |
| Long Name | TransMedics Group, Inc. |
| Market | us_market |
| Market Cap | 4,002,631,936 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_429233 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 190,291,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,002,631,587 |
| Number Of Analyst Opinions | 10 |
| Open | 113.53 |
| Operating Cashflow | 192,840,000 |
| Operating Margins | 0.13232 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Phone | 978 552 0900 |
| Post Market Change | 0.049995422 |
| Post Market Change Percent | 0.04314786 |
| Post Market Price | 115.92 |
| Post Market Time | 1,776,470,256 |
| Previous Close | 109.12 |
| Price Eps Current Year | 47.144173 |
| Price Hint | 2 |
| Price To Book | 8.392728 |
| Price To Sales Trailing12 Months | 6.6105227 |
| Profit Margins | 0.31427 |
| Quick Ratio | 6.412 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.54545 |
| Region | US |
| Regular Market Change | 6.75 |
| Regular Market Change Percent | 6.18585 |
| Regular Market Day High | 120.91 |
| Regular Market Day Low | 113.34 |
| Regular Market Day Range | 113.34 - 120.91 |
| Regular Market Open | 113.53 |
| Regular Market Previous Close | 109.12 |
| Regular Market Price | 115.87 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 971,650 |
| Return On Assets | 0.07249 |
| Return On Equity | 0.54237 |
| Revenue Growth | 0.322 |
| Revenue Per Share | 17.812 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 34,544,158 |
| Shares Percent Shares Out | 0.2325 |
| Shares Short | 8,030,292 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 8,478,217 |
| Short Name | TransMedics Group, Inc. |
| Short Percent Of Float | 0.36270002 |
| Short Ratio | 7.66 |
| Source Interval | 15 |
| State | MA |
| Symbol | TMDX |
| Target High Price | 190.0 |
| Target Low Price | 118.0 |
| Target Mean Price | 155.0 |
| Target Median Price | 154.5 |
| Total Cash | 488,366,016 |
| Total Cash Per Share | 14.237 |
| Total Debt | 519,278,016 |
| Total Revenue | 605,494,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 4.87 |
| Trailing P E | 23.792608 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 123.32603 |
| Two Hundred Day Average Change | -7.456024 |
| Two Hundred Day Average Change Percent | -0.060457833 |
| Type Disp | Equity |
| Volume | 971,650 |
| Website | https://www.transmedics.com |
| Zip | 1,810 |